
Sign up to save your podcasts
Or
Send us a text
Join Ross Lagoy and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease.
Upcoming SLAS Events:
SLAS Europe 2025 Conference and Exhibition
View the full events calendar
Send us a text
Join Ross Lagoy and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease.
Upcoming SLAS Events:
SLAS Europe 2025 Conference and Exhibition
View the full events calendar